Nasha Fitter, Vice President of Rare Disease at Ciitizen, discusses the collaboration between Ciitizen and RARE-X which will improve patient outcomes for rare diseases.
Ciitizen is a healthcare technology company that helps patients get full control of their medical records to access better treatment options including participation in research and clinical trials. RARE-X is a collaborative platform for patient controlled and structured data collection, global data sharing, and large data analysis.
As Ms. Fitter explains, partnership between these companies will not only allow RARE-X patients to easily take advantage of Ciitizen’s healthcare data infrastructure platform, but will allow biotech companies and academic researchers to collect multiple data sets about a rare disease population. Therefore, this collaboration should lead to more efficient treatment development for rare disease communities.
To stay up to date with the latest news in rare disease, sign up for our weekly newsletter here.
